BiotechTube
Home/Eisai/Koichi Yanagawa
KY

Koichi Yanagawa

Representative Director, Chairman and CEO

Eisai

Therapeutic Areas

NeurologyOncology

Eisai Pipeline

DrugIndicationPhase
Lecanemab (LEQEMBI)Alzheimer's DiseaseMarketed
Lenvatinib (LENVIMA)Renal Cell CarcinomaRegulatory Review
TaletrectinibROS1-Positive Non-Small Cell Lung CancerRegulatory Review
Lenvatinib + PembrolizumabVarious Solid TumorsPhase 3 / Marketed
Mycetoma Investigational DrugMycetomaClinical Development

Leadership Team at Eisai

HN
Haruo Naito
Former CEO, Architect of hhc Philosophy
KN
Keisuke Naito
Representative Director, President and COO
IC
Ivan Cheung
Former Chairman and CEO of Eisai Inc. (U.S.)
View full Eisai profile